Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Third Quarter Earnings
January 05 2009 - 5:00PM
PR Newswire (US)
NEW YORK, Jan. 5, 2009 /PRNewswire-FirstCall/ -- Forest
Laboratories, Inc. (NYSE:FRX), an international manufacturer and
marketer of pharmaceutical products, will release its Fiscal 2009
Third Quarter financial results before the U.S. stock market opens
on Tuesday, January 20, 2009. Later that day, at 10:00 AM EDT,
Forest will host a conference call where Dr. Lawrence Olanoff,
President and Chief Operating Officer and Frank Perier, Senior Vice
President-Finance and Chief Financial Officer, will discuss the
financial results and relevant company and industry topics. The
conference call will be webcast live beginning at 10:00 AM ET on
the Company's website http://www.frx.com/ and also on the website
http://www.streetevents.com/. Please log on to either website at
least fifteen minutes prior to the conference call as it may be
necessary to download software to access the call. A replay of the
conference call will be available until February 3, 2009 at both
websites and also by dialing 1-800-642-1687 (US investors) or
+1-706-645-9291 (international investors), ID 79863623. (LOGO:
http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO ) About
Forest Laboratories Forest Laboratories (NYSE:FRX) is a U.S.-based
pharmaceutical company with a long track record of building
partnerships and developing and marketing products that make a
positive difference in people's lives. In addition to its
well-established franchises in therapeutic areas of the central
nervous and cardiovascular systems, Forest's current pipeline
includes product candidates in all stages of development and across
a wide range of therapeutic areas. The company is headquartered in
New York, NY. To learn more about Forest Laboratories, visit
http://www.frx.com/. Except for the historical information
contained herein, this release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. These statements involve a number of risks and
uncertainties, including the difficulty of predicting FDA
approvals, the acceptance and demand for new pharmaceutical
products, the impact of competitive products and pricing, the
timely development and launch of new products, and the risk factors
listed from time to time in Forest Laboratories' Annual Report on
Form 10-K, Quarterly Report on Form 10-Q, and any subsequent SEC
filings.
http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGODATASOURCE:
Forest Laboratories, Inc. CONTACT: Frank J. Murdolo, Vice President
- Investor Relations, Forest Laboratories, Inc., +1-212-224-6714,
Web Site: http://www.frx.com/
Copyright
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024